Cody N. Bergman
Edmonton, AB T6G2N4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
68Ga-Labeled Peptides Targeting Oxytocin Receptor in Breast Cancer Using Linchpin Chemistry for Tandem Peptide Cyclization and Radiometal Chelator Incorporation.
Journal: Bioconjugate chemistry
Published: November 26, 2025
Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells.
Journal: International journal of molecular sciences
Published: February 06, 2025
Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO.
Journal: Nuclear medicine and biology
Published: March 27, 2023
Synthesis of a 2-nitroimidazole derivative N-(4-[18F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([18 F]FBNA) as PET radiotracer for imaging tumor hypoxia.
Journal: EJNMMI radiopharmacy and chemistry
Published: April 01, 2022
FOXM1 Inhibitors as Potential Diagnostic Agents: First Generation of a PET Probe Targeting FOXM1 To Detect Triple-Negative Breast Cancer in vitro and in vivo.
Journal: ChemMedChem
Published: April 23, 2021
Enrichment and ratiometric detection of circulating tumor cells using PSMA- and folate receptor-targeted magnetic and surface-enhanced Raman scattering nanoparticles.
Journal: Biomedical optics express
Published: September 21, 2020
A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models.
Journal: Nuclear medicine and biology
Published: July 09, 2020
Sulfo-click chemistry with 18F-labeled thio acids.
Journal: Chemical communications (Cambridge, England)
Published: January 12, 2019
Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents.
Journal: Nuclear medicine and biology
Published: December 13, 2017
Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile.
Journal: Molecular imaging and biology
Published: June 23, 2017
Last Updated: 09/26/2026